April 17, 2026

FTSE 100 pauses as utility sell-off offsets strength in quality growth names

FTSE 100 slips as utilities and miners drag on the index, though strength in quality growth names helps keep the wider market relatively resilient...

Physicians Capital: Why Dr. Conrad Ivie Believes Doctors Must Reclaim Ownership Before Burnout Wins (video)

Dr. Conrad Ivie breaks down why more physicians are burning out while owning less of the healthcare system they power. From building Tennessee’s largest orthopaedic group to launching Physicians Capital,..

Time Finance: How SMEs Can Strengthen Cash Flow and Thrive Through Uncertainty (video)

Cash flow, not profit, is emerging as the defining challenge for SMEs. Ed Rimmer explains why businesses must rethink funding strategies as traditional lending falls short in volatile conditions...

Abivax SA (ABVX) Stock Analysis: Understanding the 26.72% Potential Upside in Biotech Innovation

Abivax SA (ABVX) is making waves in the biotechnology sector as a promising player headquartered in Paris, France. With a market cap of $9.97 billion, this clinical-stage biotechnology company is..

Kamada Ltd. (KMDA) Stock Analysis: Assessing a 57.77% Upside Potential in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), an Israel-based leader in the specialty and generic drug manufacturing segment, is capturing investors’ attention with its promising upside potential. Currently trading at $8.24, the company’s..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Sector with a Potential 9% Upside

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) stands at an intriguing crossroads within the biotechnology sector. With a market capitalization of $492.3 million, this Boston-based company is carving a niche in..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 93% Potential Upside Amidst Analyst Enthusiasm

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a burgeoning force in the biotechnology sector, is capturing investor attention with a staggering potential upside of 93%, as projected by a consensus of market..

Eton Pharmaceuticals (ETON) Stock Analysis: Exploring a 61% Upside Potential in the Rare Disease Market

Eton Pharmaceuticals, Inc. (ETON), a specialized player in the healthcare sector focusing on treatments for rare diseases, is capturing the attention of investors with its substantial growth trajectory and potential..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 39% Potential Upside

Investors with an eye on the healthcare sector may want to take a closer look at Emergent BioSolutions Inc. (NYSE: EBS), a company renowned for its focus on providing solutions..

COMPASS Pathways Plc (CMPS) Stock Analysis: Unveiling a 226% Potential Upside in Psychedelic Therapies

For investors seeking opportunities in the healthcare sector, COMPASS Pathways Plc (NASDAQ: CMPS) presents a compelling case with its substantial potential upside. As a pioneer in the burgeoning field of..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Growth in the Medical Care Facilities Sector

Enhabit, Inc. (NASDAQ: EHAB) stands as a noteworthy player in the healthcare sector, specializing in home health and hospice services across the United States. With a market capitalization of $703.33..

Talkspace, Inc. (TALK) Stock Analysis: Exploring an 18.96% Upside in the Virtual Healthcare Arena

Investors seeking exposure to the burgeoning virtual healthcare landscape should take a closer look at Talkspace, Inc. (NASDAQ: TALK). Specializing in behavioral healthcare, Talkspace connects patients with licensed mental health..

Cogent Biosciences, Inc. (COGT) Investor Outlook: 49.67% Potential Upside in Precision Therapy Innovation

Cogent Biosciences, Inc. (NASDAQ: COGT) is capturing investor attention with its innovative approach to precision therapies targeting genetically defined diseases. As a clinical-stage biotechnology company, Cogent is pushing the boundaries..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring a 25% Potential Upside in the Biotech Sector

Fortrea Holdings Inc. (FTRE), a promising player in the healthcare sector with a focus on biotechnology, is capturing the attention of investors with a notable potential upside of 25.51%. As..

Myriad Genetics, Inc. (MYGN) Investor Outlook: Exploring Potential Upside Amidst Challenging Metrics

Investors eyeing Myriad Genetics, Inc. (NASDAQ: MYGN) are met with a complex tapestry of opportunities and challenges as they navigate the stock’s current landscape. With a market capitalization of $472.22..

Prothena Corporation (PRTA) Stock Analysis: Unveiling a Potential 99% Upside in Biotech Innovation

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company headquartered in Dublin, Ireland, stands out in the healthcare sector with its cutting-edge focus on treating diseases caused by protein dysregulation. With..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a Potential 72% Upside Amidst Healthcare Innovation

For investors seeking opportunities in the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) presents a compelling case. With a market capitalization of $432.2 million, this medical technology company is making strides..

Delcath Systems, Inc. (DCTH) Investor Outlook: A 96.98% Upside Potential in the Medical Devices Sector

Delcath Systems, Inc. (NASDAQ: DCTH) is making waves in the healthcare sector with its promising innovations in the medical devices industry, particularly focusing on the treatment of primary and metastatic..

Precigen, Inc. (PGEN) Stock Analysis: Exploring a Potential 140% Upside in the Biotech Sector

Precigen, Inc. (NASDAQ: PGEN), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors willing to navigate the volatile world of gene and cell therapies. With a..

Savara, Inc. (SVRA) Stock Analysis: A Biotech Gem with 91.71% Potential Upside

Savara, Inc. (SVRA) has recently captured the attention of investors with its promising growth potential in the biotech sector, specifically in the niche market of rare respiratory diseases. With a..

Search

Funds

April 17, 2026

FTSE 100 pauses as utility sell-off offsets strength in quality growth names

FTSE 100 slips as utilities and miners drag on the index, though strength in quality growth names helps keep the wider market relatively resilient...

Physicians Capital: Why Dr. Conrad Ivie Believes Doctors Must Reclaim Ownership Before Burnout Wins (video)

Dr. Conrad Ivie breaks down why more physicians are burning out while owning less of the healthcare system they power. From building Tennessee’s largest orthopaedic group to launching Physicians Capital, he explains why real estate, financial fluency and long-term ownership are becoming essential for doctors who want more than income tied to time...

Time Finance: How SMEs Can Strengthen Cash Flow and Thrive Through Uncertainty (video)

Cash flow, not profit, is emerging as the defining challenge for SMEs. Ed Rimmer explains why businesses must rethink funding strategies as traditional lending falls short in volatile conditions...
Search

Funds

April 17, 2026

FTSE 100

Funds